Bio-Path Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing cancer treatments. The company operates through its wholly-owned subsidiary, Bio-Path, Inc. Bio-Path develops targeted therapies for oncology indications. The filing does not provide further specific product or pipeline details within the extracted section, though the company is publicly traded on a U.S. exchange under ticker BPTH.
Q2 FY2026 — expected 2026-08-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-03-27 | 2024-12-31 | 0001558370-25-003837 | EDGAR | 70K words |
| 2024-03-07 | 2023-12-31 | 0001558370-24-002730 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0001558370-23-005081 | EDGAR | — |
| 2022-03-10 | 2021-12-31 | 0001558370-22-003298 | EDGAR | — |
| 2021-03-09 | 2020-12-31 | 0001104659-21-033789 | EDGAR | — |
| 2020-03-05 | 2019-12-31 | 0001104659-20-029711 | EDGAR | — |
| 2019-03-19 | 2018-12-31 | 0001144204-19-014855 | EDGAR | — |
| 2018-04-02 | 2017-12-31 | 0001144204-18-018611 | EDGAR | — |
| 2017-03-15 | 2016-12-31 | 0001144204-17-014602 | EDGAR | — |
| 2016-03-15 | 2015-12-31 | 0001144204-16-088178 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-01-13 | 2025-09-30 | 0001663577-26-000009 | EDGAR | 21K words |
| 2025-08-14 | 2025-06-30 | 0001558370-25-011591 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001558370-25-007887 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001558370-24-015717 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001558370-24-012259 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0001558370-24-008135 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001558370-23-019024 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001558370-23-014847 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001558370-23-009382 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001558370-22-017789 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001558370-22-013644 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001558370-22-008980 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-16 | 0001663577-26-000218 | EDGAR | — |
| 2026-03-20 | 0001663577-26-000064 | EDGAR | 1K words |
| 2026-02-24 | 0001663577-26-000046 | EDGAR | — |
| 2025-11-14 | 0001663577-25-000317 | EDGAR | — |
| 2025-10-29 | 0001663577-25-000303 | EDGAR | — |
| 2025-08-13 | 0001104659-25-077665 | EDGAR | — |
| 2025-06-24 | 0001558370-25-008814 | EDGAR | — |
| 2025-05-02 | 0001558370-25-006150 | EDGAR | — |
| 2025-04-29 | 0001104659-25-041256 | EDGAR | — |
| 2025-03-28 | 0001104659-25-029376 | EDGAR | — |
442 total filings indexed. 410 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001133818 |
| Ticker | BPTH |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/BPTH (~200 tokens, structured JSON with cryptographic provenance)